PRIMER Trademark

Trademark Overview


On Monday, August 30, 2021, a trademark application was filed for PRIMER with the United States Patent and Trademark Office. The USPTO has given the PRIMER trademark a serial number of 97002895. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, September 30, 2024. This trademark is owned by Arsenal Biosciences, Inc.. The PRIMER trademark is filed in the Pharmaceutical Products category with the following description:

Biologics for medical use, namely, biological preparations for the assessment of treatment options for, and the treatment and prophylaxis of, solid tumors and oncological diseases, disorders and conditions; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of solid tumors; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of oncological and infectious diseases, disorders and conditions; biologics for medical use, namely, biologics for the assessment of treatment options for solid tumors; biologics for medical use, namely, biologics for the assessment of treatment options for oncological and infectious diseases, disorders and conditions; biologics for medical purposes, namely, biologics for detecting the presence of malignant diseases, disorders and conditions
primer

General Information


Serial Number97002895
Word MarkPRIMER
Filing DateMonday, August 30, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, September 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBiologics for medical use, namely, biological preparations for the assessment of treatment options for, and the treatment and prophylaxis of, solid tumors and oncological diseases, disorders and conditions; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of solid tumors; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of oncological and infectious diseases, disorders and conditions; biologics for medical use, namely, biologics for the assessment of treatment options for solid tumors; biologics for medical use, namely, biologics for the assessment of treatment options for oncological and infectious diseases, disorders and conditions; biologics for medical purposes, namely, biologics for detecting the presence of malignant diseases, disorders and conditions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 13, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameArsenal Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Wednesday, October 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 2, 2021NEW APPLICATION ENTERED
Thursday, November 11, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 3, 2021ASSIGNED TO EXAMINER
Thursday, November 11, 2021NON-FINAL ACTION E-MAILED
Monday, May 9, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 13, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, February 13, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, November 11, 2021NON-FINAL ACTION WRITTEN
Monday, May 9, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 6, 2022SUSPENSION LETTER WRITTEN
Wednesday, July 6, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, July 6, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, September 9, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, November 1, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, September 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 29, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, May 3, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, June 13, 2024NON-FINAL ACTION E-MAILED
Thursday, June 13, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 30, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, September 30, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, June 13, 2024NON-FINAL ACTION WRITTEN